Scholars Central

Editor

Geeta Shroff

About

As published by the journal they serve.

Dr. Geeta Shroff has developed the technology to isolate human embryonic stem cells (hESC), culture them, prepare them for clinical application, and store them in ready-to-use form with a shelf life of six months. Further, this technology is being used clinically to treat patients. Since 2002, more than 1300 patients suffering from various conditions-Spinal cord injury, Diabetes, Multiple sclerosis, Parkinson’s disease, Cardiac conditions, Cerebral palsy - all presently categorized as incurable, have been treated by Dr. Shroff and the number is steadily growing. A graduate in medicine from the University of Delhi, Dr. Shroff did her post graduation in Gynecology & Obstetrics. A qualified IVF practitioner with vast knowledge and experience in embryology, she has been trained in all aspects of human stem cell culture, vitrification and thawing techniques. After gaining 8 years of valuable clinical experience at Safdarjung Hospital & Batra Hospital, both large multi-specialty hospitals in Delhi, Dr. Shroff set up her own IVF practice in 1996. She began research on human embryonic stem cells in 1999, and pioneered human embryonic stem cell therapy. She has presented her work at various national and international forums. Dr. Shroff envisions making hESC therapy available globally so that it becomes the first line of treatment for many of mankind’s worst afflictions

Research interests

  • Human Embryonic Stem Cell Therapy

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.